“…Designing genetically labeled VLPs that target nonenveloped viruses is conceptually not trivial as a result of the additional structural constraints (i.e., complex capsomer-folding events, increased rigidity, smaller size) (72), particularly if the cargo is to be placed inside the particle. These reagents do exist, however, despite the added complications (28,37). Such a panel of trackable, plantderived chimeric proteins and VLP reagents would be powerful tools to study VLP biology, both in the plant itself (e.g., protein expression and folding, internal tracking, particle assembly and budding) and in the mammalian immune system (e.g., trafficking, cell association, disassembly).…”